Samuel R Denmeade

26PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersPeripheral nervous systemMolecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Apr 08, 2026
Castration Resistance Accelerates Prostate Cancer Kinetics.

Sheila Jonnatan, Luka Cavka, Angelo M De Marzo

|Feb 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.

Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh

|Nov 21, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.

Rajendra Kumar, Sheila Jonnatan, David E Sanin

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Jan 28, 2025
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.

Rajendra Kumar, Janet Mendonca, Abhishek Shetty

|Jan 03, 2025
Nectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study.

Ezra G Baraban, Evangelia Vlachou, Sunil Patel

Pageof 5

Frequent Collaborators

9 joint publications

Channing J Paller

9 joint publications

Emmanuel S Antonarakis

8 joint publications

Mark Markowski

7 joint publications

Catherine H Marshall